Data sourced from ClinicalTrials.gov (NIH registry) Updated weekly IRB-supervised studies only
Home/PA/Lancaster
Updated November 2026 from ClinicalTrials.gov

Paid Clinical Trials in Lancaster, PA

Studies commonly pay $75 to $4,500 per completed study

427 clinical trials are currently recruiting participants within 30 miles of Lancaster. Listings below come straight from the official NIH registry, alongside the area's top-rated research centers with real Google reviews.

427studies recruiting
1+research centers nearby
5condition categories
Live from the NIH registry

Studies recruiting near Lancaster right now

Top 25 of 427 recruiting studies, sorted by proximity — each links to its official registry page

Real-world Experience of Catheter Ablation for the Treatment of Arrhythmias

Paroxysmal Atrial Fibrillation, Persistent Atrial Fibrillation N/A Observational 20,000 participants sought
Lancaster General Hospital — Lancaster, Pennsylvania (0.4 mi) · Sponsor: Heart Rhythm Clinical and Research Solutions, LLC

A Study to Assess Disease Activity and Adverse Events of Intravenous (IV) Telisotuzumab Vedotin Compared to IV Docetaxel in Adult Participants With Previously Treated Non-Squamous Non-Small Cell Lung Cancer (NSCLC)

Non Small Cell Lung Cancer, c-MET Phase 3 Interventional 768 participants sought
Cancer Care Associates Of York /ID# 266143 — York, Pennsylvania (23.2 mi) · Sponsor: AbbVie

Tipifarnib and Naxitamab for Relapsed/Refractory Neuroblastoma

Neuroblastoma Phase 2 Interventional 98 participants sought
Penn State Milton S. Hershey Medical Center and Children's Hospital — Hershey, Pennsylvania (25.0 mi) · Sponsor: Giselle Sholler

A Long-Term Study of ALKS 2680 in Subjects With Narcolepsy and Idiopathic Hypersomnia

Narcolepsy Type 1, Narcolepsy Type 2 Phase 2, Phase 3 Interventional 786 participants sought
Alkermes Investigational Site — Wyomissing, Pennsylvania (26.6 mi) · Sponsor: Alkermes, Inc.

VMD-928 Monotherapy and in Combination With Pembrolizumab to Treat TrkA Overexpression Driven Solid Tumors or Lymphoma

Head and Neck Carcinoma, Adenoid Cystic Carcinoma Phase 1, Phase 2 Interventional 242 participants sought
Cancer Care Associates of York (site 206) — York, Pennsylvania (23.2 mi) · Sponsor: VM Oncology, LLC

Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection

Multiple conditions N/A Observational 2,900 participants sought
Reading Hospital — West Reading, Pennsylvania (27.5 mi) · Sponsor: Alliance for Clinical Trials in Oncology

TRITON-CM: A Study to Evaluate Nucresiran in Patients With Transthyretin Amyloidosis With Cardiomyopathy

Transthyretin Amyloidosis With Cardiomyopathy Phase 3 Interventional 1,750 participants sought
Clinical Trial Site — Lancaster, Pennsylvania (0.4 mi) · Sponsor: Alnylam Pharmaceuticals

A Study of Tersolisib (LY4064809/STX-478) With Other Anti-Cancer Treatments in Participants With Advanced Breast Cancer With a Genetic Change (PIK3CA)

Breast Neoplasms, Neoplasm Metastasis Phase 3 Interventional 800 participants sought
Lancaster General Hospital - Ann B Barshinger Cancer Institute — Lancaster, Pennsylvania (0.4 mi) · Sponsor: Eli Lilly and Company

A Protocol of Icotrokinra Therapy in Adult and Adolescent Participants With Moderately to Severely Active Ulcerative Colitis

Colitis, Ulcerative Phase 3 Interventional 882 participants sought
Penn State Milton S Hershey Medical Ctr — Hershey, Pennsylvania (25.0 mi) · Sponsor: Janssen Research & Development, LLC

Inotuzumab Ozogamicin and Post-Induction Chemotherapy in Treating Patients With High-Risk B-ALL, Mixed Phenotype Acute Leukemia, and B-LLy

B Acute Lymphoblastic Leukemia, B Lymphoblastic Lymphoma Phase 3 Interventional 5,951 participants sought
Penn State Children's Hospital — Hershey, Pennsylvania (25.0 mi) · Sponsor: Children's Oncology Group

Adjuvant Pembrolizumab vs Observation Following Curative Resection for Stage I Non-small Cell Lung Cancer (NSCLC) With Primary Tumors Between 1-4 cm

NSCLC, Stage I Phase 2 Interventional 244 participants sought
Penn State Cancer Institute — Hershey, Pennsylvania (25.0 mi) · Sponsor: Greg Durm, MD

Eflornithine (DFMO) for Ewing Sarcoma and Osteosarcoma

Osteosarcoma, Ewing Sarcoma Phase 2 Interventional 406 participants sought
Penn State Milton S. Hershey Medical Center and Children's Hospital — Hershey, Pennsylvania (25.0 mi) · Sponsor: Milton S. Hershey Medical Center

A Study to See if Lepodisiran Can Reduce Plaque in Coronary Arteries of Adults With Elevated Lp(a) Who Have Had Heart Events or Are at High Risk

Atherosclerosis, Cardiovascular Diseases Phase 3 Interventional 252 participants sought
Heart and Vascular Research at WellSpan Health — York, Pennsylvania (23.2 mi) · Sponsor: Eli Lilly and Company

Repeat Biliary Point of Care Ultrasound for Detecting Early Acute Cholecystitis

Cholecystitis, Acute, Biliary Diseases N/A Interventional 90 participants sought
WellSpan Health York Hospital — York, Pennsylvania (23.2 mi) · Sponsor: WellSpan Health

Standard Systemic Therapy With or Without Definitive Treatment in Treating Participants With Metastatic Prostate Cancer

Castration Levels of Testosterone, Metastatic Prostatic Adenocarcinoma Phase 3 Interventional 1,273 participants sought
Ephrata Cancer Center — Ephrata, Pennsylvania (11.5 mi) · Sponsor: SWOG Cancer Research Network

Use of an Intrauterine Manipulator and Its Correlation with Positive Peritoneal Cytology in Early Stage Endometrial Cancers

Endometrial Cancer N/A Interventional 350 participants sought
Wellspan Health — York, Pennsylvania (23.2 mi) · Sponsor: WellSpan Health

ENdoluminal LIGHT ActivatED Treatment of Upper Tract Urothelial Cancer (ENLIGHTED) Study

Transitional Cell Cancer of Renal Pelvis and Ureter Phase 3 Interventional 100 participants sought
The Pennsylvania State University (Penn State) Milton S. Hershey Medical Center — Hershey, Pennsylvania (25.0 mi) · Sponsor: Steba Biotech S.A.

A Precision Medicine Approach Using Gene Silencing to Treat a Chronic Liver Disease Called Metabolic Dysfunction-Associated Steatohepatitis (MASH) in Adult Participants at Increased Genetic Risk for This Condition

Metabolic Dysfunction-Associated SteatoHepatitis (MASH) Phase 2 Interventional 120 participants sought
Penn State Health Milton S. Hershey Medical Center — Hershey, Pennsylvania (25.0 mi) · Sponsor: Regeneron Pharmaceuticals
Actively enrolling

Studies you may be able to join near Lancaster

These studies are recruiting through partner research networks. We may be paid a referral fee if you complete their screening form — this never changes what you pay (nothing) or the compensation the study offers you.

See which clinical studies you may qualify for

A partner research network matches volunteers with studies that are currently enrolling in the United States. You answer a few screening questions about your health and where you live; if a study looks like a fit, its team contacts you to confirm eligibility.

Screening is free and takes a few minutes. Eligibility and any compensation are confirmed by the study team, not by this site.

Google-rated

Top-rated research centers in Lancaster

Dedicated clinical research sites near you — with their real Google ratings, reviews and contact details

Clinical Research Center-Reading

2760 Century Blvd #3, Reading, PA 19610
(610) 375-2466

Clinical trials in Lancaster: what's recruiting

The Lancaster area currently has 427 studies open to new participants, according to the ClinicalTrials.gov registry maintained by the U.S. National Institutes of Health. Among the studies closest to Lancaster, the most active research areas are:

  • Cancer & Oncology11 studies
  • Liver & Kidney4 studies
  • Heart & Vascular2 studies
  • Immune & Skin1 studies
  • Diabetes & Metabolism1 studies

Every listing shows the study phase, the recruiting site and its distance from Lancaster, and links to the official registry page where eligibility criteria and study contacts are published. Compensation is set by each sponsor: industry surveys report typical payments of $75 to $4,500 per completed study, with short observational studies at the low end and multi-visit or overnight Phase 1 studies at the high end.

How to enroll in a paid study in Lancaster

Start with a study whose condition matches your profile — or a healthy-volunteer study if you have no diagnosis. Contact the research site through the registry page, complete a short phone screen, then attend an in-person screening visit. If you qualify, the study team walks you through the informed consent document, which details every procedure, risk and payment before you commit. You can withdraw at any point, and enrollment is always free.

Lancaster participants can also register with the dedicated research centers listed above — many maintain volunteer databases and call when a matching study opens — or sign up for our email alert below to hear when a new study starts recruiting within 30 miles of your ZIP code.

Frequently asked questions

How much do paid clinical trials in Lancaster pay?
Compensation varies by study length, procedures and overnight stays. Industry surveys report typical payments from $75 to $4,500 per completed study, with simple observational studies at the low end and multi-week inpatient Phase 1 studies at the high end. Each listing's study team will confirm the exact amount before you enroll.
Are clinical trials in Lancaster safe?
Every trial on this page is registered on ClinicalTrials.gov, the official NIH registry, and is overseen by an Institutional Review Board (IRB). Before joining you receive an informed consent document detailing procedures, risks and compensation. Participation is voluntary and you can withdraw at any time.
How do I join a study in Lancaster, PA?
Pick a study that matches your profile, contact the research site (or apply through the study links on this page), pass a phone pre-screen, then attend an in-person screening visit. If you qualify, you review and sign the informed consent and the study begins. The process typically takes 1-3 weeks.
Is compensation for clinical trials taxable?
In the U.S., clinical trial compensation is generally considered taxable income, and research sites may issue a 1099 form for payments above $600 in a year. Reimbursements for travel or meals are typically treated differently. Consult a tax professional for your situation.
Can I be in more than one clinical trial at a time?
Generally no — most studies exclude participants currently enrolled in another trial, and paid Phase 1 studies enforce a washout period (often 30 days or more) between studies. Frequent healthy volunteers in Lancaster typically complete one or two studies per year.

Paid clinical trials near Lancaster

Other metros within reach

By condition

Eligibility and exclusions, condition by condition

More of PA

New paid studies open every week

Get an email when a new clinical trial starts recruiting within 30 miles of your ZIP code. No spam — only real studies from the NIH registry.

Get free trial alerts